Providers-HIV Prevention Discussions with HIV-Seropositive Injection Drug Users

详细信息    查看全文

• 作者：James D. Wilkinson ; Wei Zhao ; Scott Santibanez ; Julia Arnsten ; Amy Knowlton ; Cynthia A. Gómez ; Lisa R. Metsch and INSPIRE Study Group
• 关键词：Human immunodeficiency virus ; Acquired immunodeficiency syndrome ; Substance abuse ; intravenous ; Primary health care ; Prevention and control
• 刊名：AIDS and Behavior
• 出版年：2006
• 出版时间：November, 2006
• 年：2006
• 卷：10
• 期：6
• 页码：699-705
• 全文大小：191 KB
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Public Health
  Health Psychology
  Infectious Diseases
  
• 出版者：Springer Netherlands
• ISSN：1573-3254

文摘

Public health agencies have recommended incorporating HIV prevention counseling into the medical care of persons living with HIV/AIDS. Injection drug users (IDUs) especially need HIV risk-reduction counseling because of their high risk for HIV transmission through both sexual and injection behaviors. The objective of this study was to assess the prevalence of, and patient factors associated with, the delivery of HIV prevention messages to HIV-seropositive IDUs in primary care settings. A majority of participants reported having an HIV prevention discussion with their provider during their most recent primary care visit. Factors significantly associated with report of such discussion were being Hispanic or non-Hispanic Black; high school education or less; and better perception of engagement with provider. Medical providers should provide prevention messages to all HIV-seropositive IDUs, regardless of demographic factors. Effective HIV prevention interventions in primary care settings, including interventions to improve patient-provider communication, are needed for HIV-seropositive IDUs.